دورية أكاديمية
Isolated childhood growth hormone deficiency: a 30-year experience on final height and a new prediction model
العنوان: | Isolated childhood growth hormone deficiency: a 30-year experience on final height and a new prediction model |
---|---|
المؤلفون: | Lonero, Antonella, Giotta, Massimo, Guerrini, Giulia, Calcaterra, Valeria, Galazzi, Elena, Iughetti, Lorenzo, Cassio, Alessandra, Wasniewska, Gabriela Malgorzata, Mameli, Chiara, Tornese, Gianluca, Salerno, Mariacarolina, Cherubini, Valentino, Caruso Nicoletti, Manuela, Street, Maria Elisabeth, Grandone, Anna, Giacomozzi, Claudio, Faienza, Maria Felicia, Guzzetti, Chiara, Bellone, Simonetta, Parpagnoli, Maria, Musolino, Gianluca, Maggio, Maria Cristina, Bozzola, Mauro, Trerotoli, Paolo, Delvecchio, Maurizio |
المساهمون: | Lonero, Antonella, Giotta, Massimo, Guerrini, Giulia, Calcaterra, Valeria, Galazzi, Elena, Iughetti, Lorenzo, Cassio, Alessandra, Wasniewska, Gabriela Malgorzata, Mameli, Chiara, Tornese, Gianluca, Salerno, Mariacarolina, Cherubini, Valentino, Caruso Nicoletti, Manuela, Street, Maria Elisabeth, Grandone, Anna, Giacomozzi, Claudio, Faienza, Maria Felicia, Guzzetti, Chiara, Bellone, Simonetta, Parpagnoli, Maria, Musolino, Gianluca, Maggio, Maria Cristina, Bozzola, Mauro, Trerotoli, Paolo, Delvecchio, Maurizio |
بيانات النشر: | SPRINGER |
سنة النشر: | 2022 |
المجموعة: | IRIS Università degli Studi di Palermo |
مصطلحات موضوعية: | Final height, Growth, Growth hormone deficiency, Growth hormone retesting, Insulin-like growth factor 1, LMG method, Prediction, Settore MED/38 - Pediatria Generale E Specialistica |
الوصف: | Purpose We aimed to evaluate the near-final height (nFHt) in a large cohort of pediatricpatients with growth hormone deficiency (GHD) and to elaborate a new predictive method of nFHt. Methods We recruited GHD patients diagnosed between 1987 and 2014 and followed-up until nFHt. To predict the values of nFHt, each predictor was run in a univariable spline. Results We enrolled 1051 patients. Pre-treatment height was -2.43 SDS, lower than parental height (THt) (-1.09 SDS, p < 0.001). The dose of recombinant human GH (rhGH) was 0.21mg/kg/week at start of treatment. nFHt was -1.08 SDS (height gain 1.27 SDS), higher than pre-treatment height (p < 0.001) and comparable to THt. 1.6% of the patients were shorter than -2 SDS from THt. The rhGH dose at nFHt was 0.19 mg/kg/week, lower than at the start (p < 0.001). The polynomial regression showed that nFHt was affected by gender, THt, age at puberty, height at puberty, age at the end of treatment (F = 325.37, p < 0.0001, R-2 87.2%). Conclusion This large national study shows that GHD children can reach their THt. The rhGH/kg/day dose significantly decreased from the start to the end of the treatment. Our model suggests the importance of a timely diagnosis, possibly before puberty, the beneficial effect of long-term treatment with rhGH, and the key-role of THt. Our prediction model has a very acceptable error compared to the majority of other published studies. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/35567736; info:eu-repo/semantics/altIdentifier/wos/WOS:000795642900001; numberofpages:9; journal:JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION; http://hdl.handle.net/10447/561172Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85133891699 |
DOI: | 10.1007/s40618-022-01808-4 |
الإتاحة: | https://doi.org/10.1007/s40618-022-01808-4Test http://hdl.handle.net/10447/561172Test |
حقوق: | info:eu-repo/semantics/closedAccess |
رقم الانضمام: | edsbas.1BE45460 |
قاعدة البيانات: | BASE |
DOI: | 10.1007/s40618-022-01808-4 |
---|